Schedule 13G ownership disclosure
RAPT Therapeutics Inc
Common Stock, $0.0001 par value · CUSIP: 75382E208
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LP
Shares: 1,637,165.00 · Class: 5.9%
- Roderick Wong
Shares: 1,637,165.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493215-26-000046
- Form type
- SCHEDULE 13G/A
- Filer
- RAPT Therapeutics, Inc.
- CIK
- CIK 1673772
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership